CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 1275 of 2003 entries

View as:

Neural Mechanisms for Stopping Ongoing Speech Production

Phase: N/A Priority: Normal

NCT ID: NCT05876910 Org: User:

Start: 12/08/15 End: 11/30/27 Due: 11/30/28

Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT)

Phase: N/A Priority: Normal

NCT ID: NCT03532178 Org: User:

Start: 01/01/19 End: 04/01/22 Due: 04/01/23

Postoperative Management of Groin Flaps for Vascular Coverage

Phase: N/A Priority: Normal

NCT ID: NCT03477682 Org: User:

Start: 11/07/17 End: 06/30/21 Due: 06/30/22

Healthy Mothers: an Intervention to Support Perinatal Women Living With HIV in Kenya

Phase: N/A Priority: Normal

NCT ID: NCT05219552 Org: User:

Start: 02/23/22 End: 03/09/23 Due: 03/09/24

Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Phase: N/A Priority: Normal

NCT ID: NCT00845676 Org: User:

Start: 03/31/08 End: 12/31/13 Due: 12/31/14

Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT01684293 Org: User:

Start: 07/31/13 End: 03/31/19 Due: 03/31/20

A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant

Phase: N/A Priority: Normal

NCT ID: NCT00515138 Org: User:

Start: 05/31/07 End: 11/30/11 Due: 11/30/12

Backpack Weight Impacts

Phase: N/A Priority: Normal

NCT ID: NCT04249986 Org: User:

Start: 02/21/20 End: 07/01/24 Due: 07/01/25

Uterotonic Prophylaxis Trial

Phase: N/A Priority: Normal

NCT ID: NCT02408965 Org: User:

Start: 03/31/15 End: 03/31/17 Due: 03/31/18

Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract

Phase: N/A Priority: Normal

NCT ID: NCT01175499 Org: User:

Start: 07/31/10 End: - Due: -

Pioneering Advances in Care and Education (PACE)

Phase: N/A Priority: Normal

NCT ID: NCT03397160 Org: User:

Start: 07/19/18 End: 09/30/20 Due: 09/30/21

Dyad Oxytocin Study (DOS)

Phase: N/A Priority: Normal

NCT ID: NCT02302209 Org: User:

Start: 04/30/11 End: 10/31/17 Due: 10/31/18

C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough

Phase: N/A Priority: Normal

NCT ID: NCT00221351 Org: User:

Start: 10/31/05 End: 07/31/06 Due: 07/31/07

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00295867 Org: User:

Start: 11/03/04 End: 12/31/13 Due: 12/31/14

Enhancing Collaboration Between Doctors and Patients to Improve Asthma

Phase: N/A Priority: Normal

NCT ID: NCT00201188 Org: User:

Start: 12/31/03 End: 02/29/08 Due: 02/28/09

Evaluation of Internet Access and Use in Adolescent Women Initiating Contraception

Phase: N/A Priority: Normal

NCT ID: NCT00333541 Org: User:

Start: 06/30/06 End: 07/31/08 Due: 07/31/09

Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8

Phase: N/A Priority: Normal

NCT ID: NCT02470936 Org: User:

Start: 06/30/15 End: 03/31/18 Due: 03/31/19

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)

Phase: N/A Priority: Normal

NCT ID: NCT01913340 Org: User:

Start: 09/30/13 End: 09/30/16 Due: 09/30/17

Characterizing the Synergistic Effects of Physical and Cognitive Training on Attention and Working Memory

Phase: N/A Priority: Normal

NCT ID: NCT03032796 Org: User:

Start: 01/31/17 End: 03/31/20 Due: 03/31/21

Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection

Phase: N/A Priority: Normal

NCT ID: NCT02656511 Org: User:

Start: 12/31/15 End: 05/31/28 Due: 05/31/29

Contingency Management in HIV Care for Both Stimulant Use & ART Adherence

Phase: N/A Priority: Normal

NCT ID: NCT06564792 Org: User:

Start: 09/15/23 End: 07/31/25 Due: 07/31/26

UCSF College Health Study on Contraceptive Training and Education at Community Colleges

Phase: N/A Priority: Normal

NCT ID: NCT03519685 Org: User:

Start: 04/09/18 End: 05/29/24 Due: 05/29/25

Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream

Phase: N/A Priority: Normal

NCT ID: NCT00622440 Org: User:

Start: 05/14/08 End: 12/12/12 Due: 12/12/13

The END Perioperative Smoking Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT02482233 Org: User:

Start: 08/31/15 End: 09/30/16 Due: 09/30/17

An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R) in Nyanza, Kenya

Phase: N/A Priority: Normal

NCT ID: NCT02338739 Org: User:

Start: 03/31/15 End: 11/30/20 Due: 11/30/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Neural Mechanisms for Stopping Ongoing Speech Production	NCT05876910	University of California, San Francisco	user2@example.com	None	2015-12-08	2027-11-30	2028-11-30	-	-	2025-07-14
Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT)	NCT03532178	University of California, San Francisco	user2@example.com	None	2019-01-01	2022-04-01	2023-04-01	-	-	2025-07-14
Postoperative Management of Groin Flaps for Vascular Coverage	NCT03477682	University of California, San Francisco	user2@example.com	None	2017-11-07	2021-06-30	2022-06-30	-	-	2025-07-14
Healthy Mothers: an Intervention to Support Perinatal Women Living With HIV in Kenya	NCT05219552	University of California, San Francisco	user2@example.com	None	2022-02-23	2023-03-09	2024-03-09	-	-	2025-07-14
Treatment of Acute Hepatitis C Virus in HIV Co-Infection	NCT00845676	University of California, San Francisco	user2@example.com	None	2008-03-31	2013-12-31	2014-12-31	-	-	2025-07-14
Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study	NCT01684293	University of California, San Francisco	user2@example.com	None	2013-07-31	2019-03-31	2020-03-31	-	-	2025-07-14
A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant	NCT00515138	University of California, San Francisco	user2@example.com	None	2007-05-31	2011-11-30	2012-11-30	-	-	2025-07-14
Backpack Weight Impacts	NCT04249986	University of California, San Francisco	user2@example.com	None	2020-02-21	2024-07-01	2025-07-01	-	-	2025-07-14
Uterotonic Prophylaxis Trial	NCT02408965	University of California, San Francisco	user2@example.com	None	2015-03-31	2017-03-31	2018-03-31	-	-	2025-07-14
Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract	NCT01175499	University of California, San Francisco	user2@example.com	None	2010-07-31	-	-	-	-	2025-07-14
Pioneering Advances in Care and Education (PACE)	NCT03397160	University of California, San Francisco	user2@example.com	None	2018-07-19	2020-09-30	2021-09-30	-	-	2025-07-14
Dyad Oxytocin Study (DOS)	NCT02302209	University of California, San Francisco	user2@example.com	None	2011-04-30	2017-10-31	2018-10-31	-	-	2025-07-14
C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough	NCT00221351	University of California, San Francisco	user2@example.com	None	2005-10-31	2006-07-31	2007-07-31	-	-	2025-07-14
Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer	NCT00295867	University of California, San Francisco	user2@example.com	None	2004-11-03	2013-12-31	2014-12-31	-	-	2025-07-14
Enhancing Collaboration Between Doctors and Patients to Improve Asthma	NCT00201188	University of California, San Francisco	user2@example.com	None	2003-12-31	2008-02-29	2009-02-28	-	-	2025-07-14
Evaluation of Internet Access and Use in Adolescent Women Initiating Contraception	NCT00333541	University of California, San Francisco	user2@example.com	None	2006-06-30	2008-07-31	2009-07-31	-	-	2025-07-14
Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8	NCT02470936	University of California, San Francisco	user2@example.com	None	2015-06-30	2018-03-31	2019-03-31	-	-	2025-07-14
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)	NCT01913340	University of California, San Francisco	user2@example.com	None	2013-09-30	2016-09-30	2017-09-30	-	-	2025-07-14
Characterizing the Synergistic Effects of Physical and Cognitive Training on Attention and Working Memory	NCT03032796	University of California, San Francisco	user2@example.com	None	2017-01-31	2020-03-31	2021-03-31	-	-	2025-07-14
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection	NCT02656511	University of California, San Francisco	user2@example.com	None	2015-12-31	2028-05-31	2029-05-31	-	-	2025-07-14
Contingency Management in HIV Care for Both Stimulant Use & ART Adherence	NCT06564792	University of California, San Francisco	user2@example.com	None	2023-09-15	2025-07-31	2026-07-31	-	-	2025-07-14
UCSF College Health Study on Contraceptive Training and Education at Community Colleges	NCT03519685	University of California, San Francisco	user2@example.com	None	2018-04-09	2024-05-29	2025-05-29	-	-	2025-07-14
Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream	NCT00622440	University of California, San Francisco	user2@example.com	None	2008-05-14	2012-12-12	2013-12-12	-	-	2025-07-14
The END Perioperative Smoking Pilot Study	NCT02482233	University of California, San Francisco	user2@example.com	None	2015-08-31	2016-09-30	2017-09-30	-	-	2025-07-14
An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R) in Nyanza, Kenya	NCT02338739	University of California, San Francisco	user2@example.com	None	2015-03-31	2020-11-30	2021-11-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance